Study identifier:D5160C00025
ClinicalTrials.gov identifier:NCT02756039
EudraCT identifier:N/A
CTIS identifier:N/A
Tagrisso Tablets Clinical Experience Investigation (All case investigation)
All patients treated with the product
-
No
-
All
3494
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jul 2020 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|